Abstract 2227: Physical activity at breast cancer diagnosis and incident cardiovascular disease in the Pathways Study. Read more about Abstract 2227: Physical activity at breast cancer diagnosis and incident cardiovascular disease in the Pathways Study.
Abstract 4653: Unraveling the vulnerabilities of targeted therapy-tolerant persister cells in NSCLC. Read more about Abstract 4653: Unraveling the vulnerabilities of targeted therapy-tolerant persister cells in NSCLC.
Abstract 3460: Predicting cessation of immune checkpoint inhibitor therapy due to severe adverse events with an integrated autoimmune disease polygenic risk score. Read more about Abstract 3460: Predicting cessation of immune checkpoint inhibitor therapy due to severe adverse events with an integrated autoimmune disease polygenic risk score.
Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy. Read more about Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy.
Abstract B095: Leukemia inhibitory factor fosters tumor growth in KRAS-driven pancreatic ductal adenocarcinoma. Read more about Abstract B095: Leukemia inhibitory factor fosters tumor growth in KRAS-driven pancreatic ductal adenocarcinoma.
Abstract A046: nSMase2-generated ceramide promotes PDA aggression through exosome reprogramming of the stroma. Read more about Abstract A046: nSMase2-generated ceramide promotes PDA aggression through exosome reprogramming of the stroma.
To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer. Read more about To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. Read more about The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma. Read more about PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics. Read more about Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics.
